IRCT138901292000N3已完成2 期
Buspirone versus Methylphenidate in the treatment of Attention Deficit Hyperactivity Disorder: a double-blind and randomized trial
Behavioral Sciences and Research Center of Shahid Beheshti University of Medical Sciences.0 个研究点目标入组 34 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 34
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 6 years 至 12 years（—）
- 性别
- All
入选标准
- •ADHD diagnosis according to DSM-VI criteria that scored above 20 in ADHD-Rating Scale. Exclusion criteria: evidence of a mental retardation or a major psychiatric problem other than oppositional defiant disorder and conduct disorder or receiving any psychotropic medication through 2 weeks before initiating treatment; medical disorders that would preclude the safe use of methylphenidate or buspirone.
排除标准
- 未提供
研究者
相似试验
招募中
2 期
Effect of Buspirone in ADHDAttention deficit/hyperactivity disorder.Attention-deficit hyperactivity disordersIRCT20160530028182N7Sanandaj University of Medical Sciences50
招募中
3 期
Comparison of the efficacy of Buspirone and placebo in functional abdominal pain in childreFunctional abdominal pain.Unspecified abdominal painIRCT20140304016844N3Esfahan University of Medical Sciences100
招募中
3 期
The effect of adding buspirone to SSRIs in the treatment of obsessive-compulsive disorderObsessive-compulsive disorderIRCT20180303038927N1Qazvin University of Medical Sciences60
已完成
2 期
Comparison of effect of bupropion and venlafaxine in children with hyperactivityAttention deficit hyperactivity disorder.Attention deficit: disorder with hyperactivity, hyperactivity disorder and syndrome with hyperactivityF90.0, F90IRCT201306189175N5Vice chancellor for research, Mashhad University of Medical Sciences40
进行中（未招募）
不适用
Clinical evaluation study: Bupropion versus Psychodynamic mental training according to Dr. Grohs for smoke withdrawal(Klinische Evaluierungsstudie: Bupropion versus Psychodynamisches Mentaltraining nach Dr. Grohs zur Raucherentwöhnung - Bupropion vs. PDM zur RaucherentwöhnungEUCTR2005-006189-32-ATSteiermärkische Gebietskrankenkasse